Royalty Pharma plc (NASDAQ:RPRX) Q3 2022 Earnings Call Transcript November 8, 2022
Royalty Pharma plc reports earnings inline with expectations. Reported EPS is $0.72 EPS, expectations were $0.72.
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Royalty Pharma Third Quarter Earnings Conference Call. I would now like to turn the call over to George Grofik, SVP, Head of Investor Relations and Communications. Please go ahead, sir.
Photo by Glsun Mall on Unsplash
George...
